Filing Flows › AbbVie (ABBV) › Q1 2026
AbbVie (ABBV) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 8, 2026
AbbVie (ABBV) reported revenue of $15.0B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -10% from the quarter before. Operating margin was 26.6%, net earnings $697M (4.6% of revenue).
AbbVie, Q1 2026: revenue $15.0B (+12% year over year), operating margin 26.6%, net earnings $697M, operating cash flow $3.8B. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.0B | -10% | +12% |
| Operating profit | $4.0B | -12% | +7% |
| Net earnings | $697M | -62% | -46% |
| Operating cash flow | $3.8B | -27% | +134% |
| Free cash flow | $3.6B | -27% | +155% |
What changed
Revenue was $15.0B in Q1 2026, up 12% year over year and down 10% from the previous quarter.
Operating profit was $4.0B, a 26.6% margin (down 1.4 points year over year). Of the extra revenue versus Q1 2025, 15% reached operating profit, below the 28% margin then. Total costs grew 15% against revenue growth of 12%. The fastest-growing cost line was Other operating costs (+200%). Net earnings were $0.69B, down 46% year over year. The effective tax rate was 32.9%.
Operating cash flow was $3.8B (up 134% year over year), 549% of net earnings. Non-cash charges added back $1.9B of depreciation and amortization and $0.44B of share-based compensation. Working capital and other items added $0.75B. Capital expenditures of $0.27B left free cash flow of $3.6B.
Questions
What was AbbVie's revenue in the first quarter 2026?
AbbVie (ABBV) reported revenue of $15.0B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -10% from the quarter before.
Was AbbVie profitable in the first quarter 2026?
Operating profit was $4.0B (26.6% of revenue) and net earnings $697M.
Source: AbbVie 10-Q on SEC EDGAR.